| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SUPN sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 119.6K | $5.70M | - | |
| CEO | 29.8K | $1.42M | - | |
| Dir | 3.3K | $155.2K | - | |
| VP | 2.5K | $119.1K | - | |
| VP | 1.6K | $78.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2015 | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 3,631 | $16.39 | $59,520.81 | -23.3% | |
| Mar 30, 2015 | Bryan Jones W. | VP Of Business Development | Sale+OE | 6,712 | $12.02 | $80,646.69 | -9.0% | |
| Mar 24, 2015 | Bryan Jones W. | VP Of Business Development | Sale+OE | 1,900 | $12.00 | $22,800.00 | -2.7% |